A phase II randomized trial, including 167 RA patients, showed a significant improvement in both angina symptoms and exercised tolerance with intramyocardial injection of autologous CD34+ stem cells over placebo at 6, 12 months [77] with persistent results at 24 months follow-up [78]. This evidence concerns the gene CD34 and angina pectoris.